A reduced form of nicotinamide riboside defines a new path for NAD(+) biosynthesis and acts as an orally bioavailable NAD(+) precursor

OBJECTIVE: A decay in intracellular NAD(+) levels is one of the hallmarks of physiological decline in normal tissue functions. Accordingly, dietary supplementation with NAD(+) precursors can prevent, alleviate, or even reverse multiple metabolic complications and age-related disorders in diverse mod...

詳細記述

保存先:
書誌詳細
出版年:Mol Metab
主要な著者: Giroud-Gerbetant, Judith, Joffraud, Magali, Giner, Maria Pilar, Cercillieux, Angelique, Bartova, Simona, Makarov, Mikhail V., Zapata-Pérez, Rubén, Sánchez-García, José L., Houtkooper, Riekelt H., Migaud, Marie E., Moco, Sofia, Canto, Carles
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2019
主題:
Brief Communication
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6807296/
https://ncbi.nlm.nih.gov/pubmed/31767171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2019.09.013
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料